These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7730235)

  • 41. [Microbiological study of gentamiycin].
    Chaĭkovskaia SM; Vakulenko NA; Braginskaia PS; Makarova RA
    Antibiotiki; 1975 Oct; 20(10):903-7. PubMed ID: 2095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antimicrobial activity of erythromycin and clarithromycin against clinical isolates of Escherichia coli, Staphylococcus aureus, Klebsiella and Proteus by disc diffusion method.
    Khan NW; Hassan F; Naqvi BS; Hasan SM
    Pak J Pharm Sci; 2011 Jan; 24(1):25-9. PubMed ID: 21190914
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In-vitro efficacy of cefotiam in combination with four aminoglycosides on staphylococci and Gram-negative bacteria.
    Daschner FD; Steffens A; Schneider H
    J Antimicrob Chemother; 1981 Sep; 8(3):239-41. PubMed ID: 6270053
    [No Abstract]   [Full Text] [Related]  

  • 44. The post-antibiotic effect of antimicrobial combinations in a neutropenic murine thigh infection model.
    Gudmundsson S; Einarsson S; Erlendsdottir H; Moffat J; Bayer W; Craig WA
    J Antimicrob Chemother; 1993 May; 31 Suppl D():177-91. PubMed ID: 8335520
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacodynamics of moxifloxacin and levofloxacin against Streptococcus pneumoniae, Staphylococcus aureus, Klebsiella pneumoniae and Escherichia coli: simulation of human plasma concentrations after intravenous dosage in an in vitro kinetic model.
    Odenholt I; Cars O
    J Antimicrob Chemother; 2006 Nov; 58(5):960-5. PubMed ID: 16936293
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacodynamic properties of faropenem demonstrated by studies of time-kill kinetics and postantibiotic effect.
    Boswell FJ; Andrews JM; Wise R
    J Antimicrob Chemother; 1997 Mar; 39(3):415-8. PubMed ID: 9096193
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antibiotic sensitivity of pathogenic microflora: data of the bacteriological laboratory at the antituberculosis clinic].
    Vizel' AA; Ozol SM; Guryleva ME; Gizatullina ED
    Probl Tuberk; 1998; (4):48-51. PubMed ID: 9771042
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An evaluation of the bactericidal activity of ampicillin/sulbactam, piperacillin/tazobactam, imipenem or nafcillin alone and in combination with vancomycin against methicillin-resistant Staphylococcus aureus (MRSA) in time-kill curves with infected fibrin clots.
    Palmer SM; Rybak MJ
    J Antimicrob Chemother; 1997 Apr; 39(4):515-8. PubMed ID: 9145825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro susceptibility of recently isolated gram-negative bacteria to gentamicin, sisomicin, tobramycin, and amikacin.
    Knothe H
    J Infect Dis; 1976 Nov; 134 SUPPL():S271-4. PubMed ID: 825585
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A statistical evaluation of the bactericidal effects of ceftibuten in combination with aminoglycosides and ciprofloxacin.
    Guérillot F; Carret G; Flandrois JP
    J Antimicrob Chemother; 1993 Nov; 32(5):685-94. PubMed ID: 8125833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
    Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
    Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vitro efficacy of Bay k 4999, a new ureido-penicillin, in combination with aminoglycosides against Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae and Proteus strains.
    Daschner FD; Steffens A; Langmaack H
    Chemotherapy; 1979; 25(5):282-5. PubMed ID: 113178
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [In vitro bactericidal effect of cefotetan-aminoside combinations].
    Thabaut A; Meyran M
    Pathol Biol (Paris); 1988 May; 36(5):361-5. PubMed ID: 3043329
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antibacterial activity of cefamandole in vitro.
    Meyers BR; Hirschman SZ
    J Infect Dis; 1978 May; 137 Suppl():S25-S31. PubMed ID: 349095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Bactericidal dosie-activity relationships with E. coli, K. pneumoniae and Staph. aureus (author's transl)].
    Shah PM; Junghanns ; Stille W
    Dtsch Med Wochenschr; 1976 Feb; 101(9):325-8. PubMed ID: 174881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.
    LaPlante KL; Rybak MJ
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4665-72. PubMed ID: 15561842
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Bactericidal effect of cefadroxil, amoxicillin alone or in combination with clavulanic acid in sera of healthy volunteers].
    Etesse-Carsenti H; Garraffo R; Bernard E; de Salvador F; Pradier C; Durant J; Mondain V; Drugeon HB; Dellamonica P
    Pathol Biol (Paris); 1991 Dec; 39(10):972-7. PubMed ID: 1805138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Bactericidal activity of daptomycin and vancomycin alone or in combination with tobramycin, netilmicin or ampicillin against enterococcus].
    Duez JM; Péchinot A; Siébor E; Cordin X; Kazmierczak A
    Pathol Biol (Paris); 1989 Apr; 37(4):263-8. PubMed ID: 2543946
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparative in vitro activity of dibekacin, gentamicin and tobramycin on 617 bacterial strains].
    Coulet M; Brun Y; Forey F; Fleurette J
    Nouv Presse Med; 1982 Nov; 11(46):3391-5. PubMed ID: 7155846
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differences between cephalothin and newer parenterally absorbed cephalosporins in vitro: a justification for separate disks.
    Washington JA II
    J Infect Dis; 1978 May; 137 Suppl():S32-S37. PubMed ID: 349096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.